|  |  | 

India Top Headlines

Serum Institute Plans to Start Covid Vaccine Production Outside of India: Report | India News

img-responsive

NEW DELHI: The Serum Institute of India, which makes the AstraZeneca Covid-19 vaccine, plans to start vaccine production in other countries as it struggles to meet supply commitments, its CEO told The Times.
“There will be an announcement in the next few days,” Adar Poonawalla said, as quoted by the newspaper in an interview published on Friday.
Poonawalla said last week that the Serum Institute could increase its monthly production to 100 million doses by July, later than an earlier schedule in late May. Several states in India have run out of Covid-19 vaccines.
It expected to increase the Serum Institute’s production capacity from 2.5 billion to 3 billion doses a year in six months, the Times reported, adding that it flew to London before Britain banned travelers from India eight days ago.
Coronavirus cases and deaths have risen in India as the world’s second-most populous country has reported more than 300,000 new infections daily for nine consecutive days, hitting another world record of 386,452 on Friday.
The increase has sparked a public health crisis and forced the government to seek oxygen, medicine and other basic goods abroad.
Coronavirus cases in the nation may peak between May 3-5, according to scientists advising the government.
Some health experts said that India became complacent when new cases were registered at around 10,000 per day and the new coronavirus appeared to be under control. The authorities lifted the restrictions, allowing the resumption of large festivals and political demonstrations.

Times of India

serum-institute-plans-to-start-covid-vaccine-production-outside-of-india-report-india-news

ABOUT THE AUTHOR